Links

Only ⅔ of FDA-approved biosimilars have launched.Measles outbreak continues.UnitedHealth profits fall.Super-Earths.‘Bone Collector’ caterpillars.NFL Draft comes to Green Bay.

Read More

Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers. The post Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation appeared first on MedCity News.

Read More

CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies

Caribou Biosciences’ restructuring narrows the biotech’s focus to two off-the-shelf cell therapies for blood cancers, whose key data readouts have been pushed out to the second half of 2025. It’s the CRISPR-editing company’s second cash-saving restructuring in the past year. The post CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on…

Read More

Potential Implications of Immigration Restrictions on the U.S. Agricultural Workforce

Using data from the 2022 National Agricultural Workers Survey (NAWS), this issue brief examines key characteristics of agricultural workers, including their citizenship status, health coverage, and access to health care. The Trump administration’s restrictive immigration policies may compound health challenges and risks this groups faces and have negative impacts on the cost and availability of…

Read More